Skip to main content

Animations

MJFF Publications

2641 - 2650 of 8404 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2021.110090
    Citation Count: 78
  • Summary Details
    RESTRICTED
    Title: An atypical ubiquitin ligase at the heart of neural development and programmed axon degeneration
    Journal Name: Neural Regeneration Research
    Publisher: Medknow
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.4103/1673-5374.338992
    Citation Count: 8
  • Summary Details
    RESTRICTED
    Title: Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.jbc.2021.101478
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Association between cigarette smoking and Parkinson’s disease: a neuroimaging study
    Journal Name: Therapeutic Advances in Neurological Disorders
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/17562864221092566
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Association of vitamin K with cognitive decline and neuropathology in community‐dwelling older persons
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/trc2.12255
    Citation Count: 39
  • Summary Details
    OPEN
    Title: At a Glance: An Update on Neuroimaging and Retinal Imaging in Alzheimer’s Disease and Related Research
    Journal Name: The Journal of Prevention of Alzheimer's Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.14283/jpad.2022.7
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: c‐Abl Inhibitors as Disease‐Modifying Therapies for Parkinson's Disease: Gaps and Opportunities
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28907
    Best OA location URL:
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [18F]FEOBV PET study
    Journal Name: Aging Brain
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbas.2022.100039
    Citation Count: 29
  • Summary Details
    RESTRICTED
    Title: Characterization of Axon Guidance Phenotypes in Wnt/PCP Mutant Mice
    Journal Name: Methods in Molecular Biology
    Publisher: Springer US
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/978-1-0716-2035-9_17
    Best OA location URL:
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: Clinical neurophysiology of Parkinson’s disease and parkinsonism
    Journal Name: Clinical Neurophysiology Practice
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.cnp.2022.06.002
    Citation Count: 33
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.